Full name
GENEME MOLECULAR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
GENEME MOLECULAR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. KAMPINOSKA 25, 80-180 GDAŃSK
TAX ID5833440725
Rate company:
GENEME MOLECULAR SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5833440725
KRS0000933347
Share capital5,000.00 zł
address
UL. KAMPINOSKA 25, 80-180 GDAŃSK
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5833440725
REGON
520522701
KRS
0000933347
Legal form
limited liability company
Register Address
UL. KAMPINOSKA 25, 80-180 GDAŃSK
Date of registration in KRS
2021-11-24
Date of commencement of economic activity
2021-11-24
Act signature
GD.VII NS-REJ.KRS/11923/24/846/ADE
Pkd codes
86.90.E - Healthcare
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.91.Z - Intermediary retail sale, non-specialized
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
75.00.Z - Veterinary activities
82.99.Z - Other business support activities, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL76 1140 1140 0000 2723 6400 1007 
PL06 1140 1140 0000 2723 6400 1006 PL87 1140 1140 0000 2723 6400 1003 PL60 1140 1140 0000 2723 6400 1004 PL44 1140 1140 0000 2723 6400 1001 PL17 1140 1140 0000 2723 6400 1002 Show more bank accounts from VAT list (3)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2022 | 2023 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss)  | -91,9 | 107,2 | 216,7 |
EBITDA | -85,1 | 122,6 | 244,1 |
Short time liabilities | 214,3 | 346,8 | 61,8 |
Equity capital | -86,9 | 15,7 | 118,1 |
Operating profit (EBIT) | -85,1 | 122,6 | 244,1 |
Assets | 197,3 | 437,5 | 121,7 |
Net profit (loss) | -91,9 | 102,6 | 211,7 |
Cash | 119,1 | 51,5 | -56,7 |
Net income from sale | 48,8 | 346 | 609 |
Liabilities and provisions for liabilities | 284,2 | 421,8 | 48,4 |
Working assets | 197,3 | 437,5 | 121,7 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 105,8 | 652,9 | 547,1 |
Equity capital to total assets | -44 | 3,6 | 47,6 |
Gross profit margin | -188,2 | 31 | 219,2 |
EBITDA Margin | -174,4 | 35,4 | 209,8 |
Days | Days | Days | |
Short term commitment turnover cycle | 1603 | 366 | -1237 |
Current financial liquidity indicator | 0.9208245873451233 | 1.2615247964859009 | 0,4 |
Net dept to EBITDA | 0.5782078504562378 | 1.5821068286895752 | 1 |
Financial statements
01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.